文献速递认知障碍与痴呆

联合连接组学、MAPT基因表达与淀粉样蛋白沉积解释阿尔茨海默病区域性tau沉积

Combined Connectomics, MAPT Gene Expression, and Amyloid Deposition to Explain Regional Tau Deposition in Alzheimer Disease.
PubMed 文献 · Ann Neurol · 2023-10-25

研究纳入3项研究共685名参与者(395名淀粉样蛋白阳性AD谱系患者和290名淀粉样蛋白阴性对照),利用静息态功能连接、MAPT基因表达和淀粉样蛋白PET预测tau-PET的区域分布。结果显示,联合三种模态较单一模态显著提高了解释方差,为解释AD中tau沉积的区域易感性提供了工具。

要点

  • 在淀粉样蛋白阳性参与者中,功能连接单独解释tau-PET区域值方差的21.8%至39.2%(范围跨3项研究)。
  • 逐步加入MAPT基因表达和淀粉样蛋白PET后,解释方差分别提高至30.2%至46.0%和45.0%至49.9%。
  • 联合三种预测因子对患者个体水平tau-PET区域值的解释方差(平均调整R²范围跨研究)为0.251至0.333,高于连接单独(0.118至0.148)和连接加MAPT表达(0.156至0.196)。

核心结论

  • 在3个研究样本中,联合功能连接组和分子特征较单一模态大幅提升了解释力,为解释AD中tau沉积的区域易感性提供了有价值的工具。

研究设计与样本

  • 研究纳入685名参与者(395名淀粉样蛋白阳性AD谱系参与者和290名淀粉样蛋白阴性对照),来自3项研究(阿尔茨海默病神经影像学倡议、18F-AV-1451-A05和BioFINDER-1),均具有tau-PET和淀粉样蛋白PET数据。
  • 从人类连接组计划健康对照(n=1,000)获取静息态功能磁共振成像,从艾伦人脑图谱获取MAPT基因表达。
  • 基于叠加于所有模态的脑分区图谱,获取感兴趣区(ROI)间功能连接、ROI水平PET值和MAPT基因表达;采用逐步回归分析检验连接、MAPT基因表达和淀粉样蛋白PET对淀粉样蛋白阳性参与者组平均和个体tau-PET ROI值的预测作用。

主要发现

  • 连接单独解释淀粉样蛋白阳性参与者组平均tau-PET ROI值方差的21.8%至39.2%(范围跨3项研究)。
  • 逐步加入MAPT基因表达和淀粉样蛋白PET后,解释方差分别提高至30.2%至46.0%和45.0%至49.9%。
  • 对患者个体水平tau-PET ROI值的预测,联合所有3种预测因子显著改善了解释的变异(平均调整R²范围跨研究:连接单独为0.118-0.148,连接加MAPT表达为0.156-0.196,三种模态联合为0.251-0.333)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: We aimed to test whether region-specific factors, including spatial expression patterns of the tau-encoding gene MAPT and regional levels of amyloid positron emission tomography (PET), enhance connectivity-based modeling of the spatial variability in tau-PET deposition in the Alzheimer disease (AD) spectrum. METHODS: We included 685 participants (395 amyloid-positive participants within AD spectrum and 290 amyloid-negative controls) with tau-PET and amyloid-PET from 3 studies (Alzheimer's Disease Neuroimaging Initiative, 18 F-AV-1451-A05, and BioFINDER-1). Resting-state functional magnetic resonance imaging was obtained in healthy controls (n = 1,000) from the Human Connectome Project, and MAPT gene expression from the Allen Human Brain Atlas. Based on a brain-parcellation atlas superimposed onto all modalities, we obtained region of interest (ROI)-to-ROI functional connectivity, ROI-level PET values, and MAPT gene expression. In stepwise regression analyses, we tested connectivity, MAPT gene expression, and amyloid-PET as predictors of group-averaged and individual tau-PET ROI values in amyloid-positive participants. RESULTS: Connectivity alone explained 21.8 to 39.2% (range across 3 studies) of the variance in tau-PET ROI values averaged across amyloid-positive participants. Stepwise addition of MAPT gene expression and amyloid-PET increased the proportion of explained variance to 30.2 to 46.0% and 45.0 to 49.9%, respectively. Similarly, for the prediction of patient-level tau-PET ROI values, combining all 3 predictors significantly improved the variability explained (mean adjusted R2 range across studies = 0.118-0.148, 0.156-0.196, and 0.251-0.333 for connectivity alone, connectivity plus MAPT expression, and all 3 modalities combined, respectively). INTERPRETATION: Across 3 study samples, combining the functional connectome and molecular properties substantially enhanced the explanatory power compared to single modalities, providing a valuable tool to explain regional susceptibility to tau deposition in AD. ANN NEUROL 2024;95:274-287.

来源:Ann Neurol,查看原文。版权归原作者所有。

引用

  1. Zheng L, Rubinski A, Denecke J, et al. Combined Connectomics, MAPT Gene Expression, and Amyloid Deposition to Explain Regional Tau Deposition in Alzheimer Disease. Ann Neurol. 2023. PMID: 37837382. doi:10.1002/ana.26818

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。